Skip to main content

Publications searcher

The science produced by our scientists is very important. In 2024, 1,501 papers were published in scientific journals with an average impact factor of over 7.13 points.

Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases.

PMID: 31516692
Journal: Clinical and Translational Allergy
Year: 2019
Reference: Clin Transl Allergy. 2019 Sep 9;9:44. doi: 10.1186/s13601-019-0279-2. eCollection 2019.
Impact factor:
Publication type: Review in international publication
Authors: Aberer, W; Agache, I; Agache, Ioana; Akdis, C A; Akdis, Cezmi A; Akdis, M; Aliberti, M R; Almeida, R; Amat, F; Angles, R et al.
DOI: 10.1186/s13601-019-0279-2

Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 1).

PMID: 31559071
Journal: Journal of Thoracic Disease
Year: 2019
Reference: J Thorac Dis. 2019 Aug;11(8):3633-3642. doi: 10.21037/jtd.2019.08.64.
Impact factor: 2.027
Publication type: Paper in international publication
Authors: Tsiligianni, Ioanna, Bousquet, Jean, Pham-Thi, Nhan, Bedbrook, Anna, Agache, Ioana, Annesi-Maesano, Isabella, Ansotegui, Ignacio, Anto, Josep M, Bachert, Claus, Benveniste, Samuel et al.
DOI: 10.21037/jtd.2019.08.64

Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 2).

PMID: 31656683
Journal: Journal of Thoracic Disease
Year: 2019
Reference: J Thorac Dis. 2019 Sep;11(9):4072-4084. doi: 10.21037/jtd.2019.09.38.
Impact factor: 2.027
Publication type: Review in international publication
Authors: Williams, Sian, Pham-Thi, Nhan, Bedbrook, Anna, Agache, Ioana, Annesi-Maesano, Isabella, Ansotegui, Ignacio, Anto, Josep M, Bachert, Claus, Benveniste, Samuel, Bewick, Mike et al.
DOI: 10.21037/jtd.2019.09.38

Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 1).

PMID: 31559071
Journal: Journal of Thoracic Disease
Year: 2019
Reference: J Thorac Dis. 2019 Aug;11(8):3633-3642. doi: 10.21037/jtd.2019.08.64.
Impact factor:
Publication type: Paper in international publication
Authors: Agache, Ioana; Annesi-Maesano, Isabella; Ansotegui, Ignacio; Anto, Josep M; Bachert, Claus; Bedbrook, Anna; Benveniste, Samuel; Bewick, Mike; Billo, Nils; Bosnic-Anticevich, Sinthia et al.
DOI: 10.21037/jtd.2019.08.64

Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 2).

PMID: 31656683
Journal: Journal of Thoracic Disease
Year: 2019
Reference: J Thorac Dis. 2019 Sep;11(9):4072-4084. doi: 10.21037/jtd.2019.09.38.
Impact factor:
Publication type: Review in international publication
Authors: Agache, Ioana; Annesi-Maesano, Isabella; Ansotegui, Ignacio; Anto, Josep M; Bachert, Claus; Bedbrook, Anna; Benveniste, Samuel; Bewick, Mike; Billo, Nils; Bosnic-Anticevich, Sinthia et al.
DOI: 10.21037/jtd.2019.09.38

Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial.

PMID: 31103412
Journal: Lancet Respiratory Medicine
Year: 2019
Reference: Lancet Respir Med. 2019 Jul;7(7):569-580. doi: 10.1016/S2213-2600(19)30139-0. Epub 2019 May 15.
Impact factor: 22.992
Publication type: Paper in international publication
Authors: Nowak, Anna K, Scagliotti, Giorgio V, Gaafar, Rabab, Popat, Sanjay, Vogelzang, Nicholas J, Grosso, Federica, Aboelhassan, Rasha, Jakopovic, Marko, Ceresoli, Giovanni L, Taylor, Paul et al.
DOI: 10.1016/S2213-2600(19)30139-0

Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial.

PMID: 31103412
Journal: Lancet Respiratory Medicine
Year: 2019
Reference: Lancet Respir Med. 2019 Jul;7(7):569-580. doi: 10.1016/S2213-2600(19)30139-0. Epub 2019 May 15.
Impact factor:
Publication type: Paper in international publication
Authors: Aboelhassan, Rasha; Barrueco, Jose; Cedres, Susana; Ceresoli, Giovanni L; Fennell, Dean A; Gaafar, Rabab; Grosso, Federica; Jakopovic, Marko; Kim, Miyoung; Kuribayashi, Kozo et al.
DOI: 10.1016/S2213-2600(19)30139-0

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.

PMID: 31566307
Journal: NEW ENGLAND JOURNAL OF MEDICINE
Year: 2019
Reference: N Engl J Med. 2019 Oct 31;381(18):1718-1727. doi: 10.1056/NEJMoa1908681. Epub 2019 Sep 29.
Impact factor: 70.67
Publication type: Paper in international publication
Authors: Abe, S, Flaherty, Kevin R, Wells, Athol U, Cottin, Vincent, Devaraj, Anand, Walsh, Simon L F, Inoue, Yoshikazu, Richeldi, Luca, Kolb, Martin, Tetzlaff, Kay et al.
DOI: 10.1056/NEJMoa1908681

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.

PMID: 31566307
Journal: NEW ENGLAND JOURNAL OF MEDICINE
Year: 2019
Reference: N Engl J Med. 2019 Oct 31;381(18):1718-1727. doi: 10.1056/NEJMoa1908681. Epub 2019 Sep 29.
Impact factor:
Publication type: Paper in international publication
Authors: Abe, S; Aburto, M; Acosta, O; Andrews, C; Antin-Ozerkis, D; Arce, G; Arias, M; Avdeev, S; Barczyk, A; Bascom, R et al.
DOI: 10.1056/NEJMoa1908681

Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial.

PMID: 31173551
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2019
Reference: J Clin Oncol. 2019 Nov 10;37(32):2968-2973. doi: 10.1200/JCO.18.02238. Epub 2019 Jun 7.
Impact factor: 28.245
Publication type: Paper in international publication
Authors: Del Campo, Josep M, Matulonis, Ursula A, Malander, Susanne, Provencher, Diane, Mahner, Sven, Follana, Philippe, Waters, Justin, Berek, Jonathan S, Woie, Kathrine, Oza, Amit M et al.
DOI: 10.1200/JCO.18.02238

Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial.

PMID: 31173551
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2019
Reference: J Clin Oncol. 2019 Nov 10;37(32):2968-2973. doi: 10.1200/JCO.18.02238. Epub 2019 Jun 7.
Impact factor:
Publication type: Paper in international publication
Authors: Arora, Sujata; Benigno, Benedict; Berek, Jonathan S; Canzler, Ulrich; Del Campo, Josep M; Follana, Philippe; Gil-Martin, Marta; Gilbert, Lucy; Hazard, Sebastien J; Lesoin, Anne et al.
DOI: 10.1200/JCO.18.02238

Nomogram for Predicting Survival in Patients Treated with Liposomal Irinotecan Plus Fluorouracil and Leucovorin in Metastatic Pancreatic Cancer.

PMID: 31357748
Journal: Cancers
Year: 2019
Reference: Cancers (Basel). 2019 Jul 28;11(8). pii: cancers11081068. doi: 10.3390/cancers11081068.
Impact factor: 6.162
Publication type: Paper in international publication
Authors: Blanc, Jean-Frederic, Mirakhur, Beloo, Jong, Floris A de, Belanger, Bruce, Bekaii-Saab, Tanios, Siveke, Jens T, Macarulla, Teresa, Chen, Li-Tzong et al.
DOI: 10.3390/cancers11081068

Nomogram for Predicting Survival in Patients Treated with Liposomal Irinotecan Plus Fluorouracil and Leucovorin in Metastatic Pancreatic Cancer.

PMID: 31357748
Journal: Cancers
Year: 2019
Reference: Cancers (Basel). 2019 Jul 28;11(8). pii: cancers11081068. doi: 10.3390/cancers11081068.
Impact factor:
Publication type: Paper in international publication
Authors: Bekaii-Saab, Tanios; Belanger, Bruce; Blanc, Jean-Frederic; Chen, Li-Tzong; Jong, Floris A de; Macarulla, Teresa; Mirakhur, Beloo; Siveke, Jens T et al.
DOI: 10.3390/cancers11081068

Noncanonical TGFbeta Pathway Relieves the Blockade of IL1beta/TGFbeta-Mediated Crosstalk between Tumor and Stroma: TGFBR1 and TAK1 Inhibition in Colorectal Cancer.

PMID: 30979739
Journal: CLINICAL CANCER RESEARCH
Year: 2019
Reference: Clin Cancer Res. 2019 Jul 15;25(14):4466-4479. doi: 10.1158/1078-0432.CCR-18-3957. Epub 2019 Apr 12.
Impact factor:
Publication type: Paper in international publication
Authors: Albert, Nerea; Berdiel-Acer, Mireia; Capella, Gabriel; Cimas, Francisco J; Garcia, Elena; Garcia-Vicien, Gemma; Goncalves-Ribeiro, Samuel; Guillen Diaz-Maroto, Natalia; Mollevi, David G; Moreno, Victor et al.
DOI: 10.1158/1078-0432.CCR-18-3957

Noncontrast Computed Tomography Alberta Stroke Program Early CT Score May Modify Intra-Arterial Treatment Effect in DAWN.

PMID: 31345135
Journal: STROKE
Year: 2019
Reference: Stroke. 2019 Sep;50(9):2404-2412. doi: 10.1161/STROKEAHA.118.024583. Epub 2019 Jul 26.
Impact factor: 6.046
Publication type: Paper in international publication
Authors: Haussen, Diogo C, Bonafe, Alain, Budzik, Ronald J, Yavagal, Dileep R, Hanel, Ricardo A, Hassan, Ameer E, Ribo, Marc, Cognard, Christophe, Sila, Cathy A, Morgan, Patricia M et al.
DOI: 10.1161/STROKEAHA.118.024583

Noncontrast Computed Tomography Alberta Stroke Program Early CT Score May Modify Intra-Arterial Treatment Effect in DAWN.

PMID: 31345135
Journal: STROKE
Year: 2019
Reference: Stroke. 2019 Sep;50(9):2404-2412. doi: 10.1161/STROKEAHA.118.024583. Epub 2019 Jul 26.
Impact factor:
Publication type: Paper in international publication
Authors: Bhuva, Parita; Bonafe, Alain; Budzik, Ronald J; Cognard, Christophe; Hanel, Ricardo A; Hassan, Ameer E; Haussen, Diogo C; Jadhav, Ashutosh P; Jovin, Tudor G; Liebeskind, David S et al.
DOI: 10.1161/STROKEAHA.118.024583

Non-eosinophilic severe exacerbations of COPD: what about antibiotics?

PMID: 31645283
Journal: Lancet Respiratory Medicine
Year: 2019
Reference: Lancet Respir Med. 2019 Nov;7(11):e33. doi: 10.1016/S2213-2600(19)30347-9.
Impact factor: 22.992
Publication type: Letter or abstract
Authors: Miravitlles, Marc, Llor, Carl et al.
DOI: 10.1016/S2213-2600(19)30347-9

Non-eosinophilic severe exacerbations of COPD: what about antibiotics?

PMID: 31645283
Journal: Lancet Respiratory Medicine
Year: 2019
Reference: Lancet Respir Med. 2019 Nov;7(11):e33. doi: 10.1016/S2213-2600(19)30347-9.
Impact factor:
Publication type: Letter or abstract
Authors: Llor, Carl; Miravitlles, Marc et al.
DOI: 10.1016/S2213-2600(19)30347-9

Non-inferiority of dose reduction versus standard dosing of TNF-inhibitors in axial spondyloarthritis.

PMID: 30621746
Journal: ARTHRITIS RESEARCH & THERAPY
Year: 2019
Reference: Arthritis Res Ther. 2019 Jan 8;21(1):11. doi: 10.1186/s13075-018-1772-z.
Impact factor: 4.148
Publication type: Paper in international publication
Authors: Rodriguez-Lozano, Carlos, Linares, Luis Francisco, Urruticoechea, Ana, Collantes, Eduardo, Morla, Rosa Maria, Reina, Delia, Cuende, Eduardo, Zarco, Pedro, Fernandez-Espartero, Maria Cruz, Garcia-Vicuna, Rosario et al.
DOI: 10.1186/s13075-018-1772-z

Non-inferiority of dose reduction versus standard dosing of TNF-inhibitors in axial spondyloarthritis.

PMID: 30621746
Journal: ARTHRITIS RESEARCH & THERAPY
Year: 2019
Reference: Arthritis Res Ther. 2019 Jan 8;21(1):11. doi: 10.1186/s13075-018-1772-z.
Impact factor:
Publication type: Paper in international publication
Authors: Albinana, Nestor; Almirall, Miriam; Aparicio, Maria; Ariza, Rafael; Avendano, Cristina; Batlle, Enrique; Calvo, Gonzalo; Campos, Cristina; Clavaguera, Teresa; Collantes, Eduardo et al.
DOI: 10.1186/s13075-018-1772-z

Non-intravenous carbapenem-sparing antibiotics for the definitive treatment of bacteremia due to Enterobacteriaceae-producing ESBL or AmpC beta-lactamase. A propensity score study.

PMID: 31075401
Journal: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
Year: 2019
Reference: Int J Antimicrob Agents. 2019 Aug;54(2):189-196. doi: 10.1016/j.ijantimicag.2019.05.004. Epub 2019 May 7.
Impact factor: 4.615
Publication type: Paper in international publication
Authors: Ayestaran, Ana, Morales-Cartagena, Alejandra, Ribera, Alba, Duarte, Alejandra, Abelenda, Gabriela, Rodriguez-Bano, Jesus, Martinez-Montauti, Joaquim, Sierra, Montserrat, Loureiro-Amigo, Jose, Ortega, Lucia et al.
DOI: 10.1016/j.ijantimicag.2019.05.004

Non-intravenous carbapenem-sparing antibiotics for the definitive treatment of bacteremia due to Enterobacteriaceae-producing ESBL or AmpC beta-lactamase. A propensity score study.

PMID: 31075401
Journal: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
Year: 2019
Reference: Int J Antimicrob Agents. 2019 Aug;54(2):189-196. doi: 10.1016/j.ijantimicag.2019.05.004. Epub 2019 May 7.
Impact factor:
Publication type: Paper in international publication
Authors: Abelenda, Gabriela; Ayestaran, Ana; Clemente, Mercedes; Duarte, Alejandra; Fernandez-Hidalgo, Nuria; Loureiro-Amigo, Jose; Martinez-Montauti, Joaquim; Meije, Yolanda; Morales-Cartagena, Alejandra; Ortega, Lucia et al.
DOI: 10.1016/j.ijantimicag.2019.05.004

Noninvasive approach for de novo acute hypoxemic respiratory failure: noninvasive ventilation, high-flow nasal cannula, both or none?

PMID: 30516585
Journal: Current Opinion in Critical Care
Year: 2019
Reference: Curr Opin Crit Care. 2019 Feb;25(1):54-62. doi: 10.1097/MCC.0000000000000570.
Impact factor: 2.54
Publication type: Paper in international publication
Authors: Garcia-de-Acilu, Marina, Patel, Bhakti K, Roca, Oriol et al.
DOI: 10.1097/MCC.0000000000000570

Noninvasive approach for de novo acute hypoxemic respiratory failure: noninvasive ventilation, high-flow nasal cannula, both or none?

PMID: 30516585
Journal: Current Opinion in Critical Care
Year: 2019
Reference: Curr Opin Crit Care. 2019 Feb;25(1):54-62. doi: 10.1097/MCC.0000000000000570.
Impact factor:
Publication type: Paper in international publication
Authors: Garcia-de-Acilu, Marina; Patel, Bhakti K; Roca, Oriol et al.
DOI: 10.1097/MCC.0000000000000570